Taipei, Taiwan

Yih-Jing Lee

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yih-Jing Lee. Retrieved from https://idiyas.com/inventor/yih-jing-lee-qjp57p85

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yih-Jing Lee: Innovator in Retinal Treatment

Introduction

Yih-Jing Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal disorders. His innovative approach has led to the development of methods that address retinal degeneration caused by retinal vein occlusion or retinal ischemia.

Latest Patents

Yih-Jing Lee holds 1 patent for his groundbreaking work titled "Methods of treating a retinal degenerative disorder." This patent reflects his commitment to advancing medical treatments and improving patient outcomes in retinal health.

Career Highlights

Lee is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

One of his notable collaborators is Hung Li, with whom he has worked closely on various projects related to retinal health. Their partnership exemplifies the importance of teamwork in driving innovation in medical science.

Conclusion

Yih-Jing Lee's contributions to the field of retinal treatment highlight his dedication to improving healthcare through innovation. His work continues to inspire future advancements in the treatment of retinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…